Related Articles
CLPTM1L expression predicts recurrence of patients with intermediate‑ and high‑risk stage IB‑IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherapy
Favorable outcomes of localized synovial sarcoma patients with a high utilization rate of neoadjuvant and/or adjuvant chemotherapy
3-year treatment with recombinant interferon-alpha as adjuvant therapy of cutaneous malignant melanoma.
Impact of the duration of hormonal therapy following radiotherapy for localized prostate cancer
Toxicity of adjuvant high-dose interferon-alpha-2b in patients with cutaneous melanoma at high risk of recurrence.